PT  - JOURNAL ARTICLE
AU  - Q. Sue Huang
AU  - Tim Wood
AU  - Lauren Jelley
AU  - Tineke Jennings
AU  - Sarah Jefferies
AU  - Karen Daniells
AU  - Annette Nesdale
AU  - Tony Dowell
AU  - Nikki Turner
AU  - Priscilla Campbell-Stokes
AU  - Michelle Balm
AU  - Hazel C Dobinson
AU  - Cameron C. Grant
AU  - Shelley James
AU  - Nayyereh Aminisani
AU  - Jacqui Ralston
AU  - Wendy Gunn
AU  - Judy Bocacao
AU  - Jessica Danielewicz
AU  - Tessa Moncrieff
AU  - Andrea McNeill
AU  - Liza Lopez
AU  - Ben Waite
AU  - Tomasz Kiedrzynski
AU  - Hannah Schrader
AU  - Rebekah Gray
AU  - Kayla Cook
AU  - Danielle Currin
AU  - Chaune Engelbrecht
AU  - Whitney Tapurau
AU  - Leigh Emmerton
AU  - Maxine Martin
AU  - Michael G. Baker
AU  - Susan Taylor
AU  - Adrian Trenholme
AU  - Conroy Wong
AU  - Shirley Lawrence
AU  - Colin McArthur
AU  - Alicia Stanley
AU  - Sally Roberts
AU  - Fahimeh Ranama
AU  - Jenny Bennett
AU  - Chris Mansell
AU  - Meik Dilcher
AU  - Anja Werno
AU  - Jennifer Grant
AU  - Antje van der Linden
AU  - Ben Youngblood
AU  - Paul G. Thomas
AU  - Richard J. Webby
AU  - on behalf of the investigation team
TI  - Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand
AID  - 10.1101/2020.11.11.20228692
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.11.11.20228692
4099  - http://medrxiv.org/content/early/2020/11/13/2020.11.11.20228692.short
4100  - http://medrxiv.org/content/early/2020/11/13/2020.11.11.20228692.full
AB  - Stringent nonpharmaceutical interventions (NPIs) such as lockdowns and border closures are not currently recommended for pandemic influenza control. New Zealand used these NPIs to eliminate coronavirus disease 2019 during its first wave. Using multiple surveillance systems, we observed a parallel and unprecedented reduction of influenza and other respiratory viral infections in 2020. This finding supports the use of these NPIs for controlling pandemic influenza and other severe respiratory viral threats.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe SHIVERS-II project is funded by US National Institute of Allergy and Infectious Diseases (NIAID) (CEIRS Contract HHSN272201400006C). The WellKiwis (i.e. SHIVERS-III) project is funded by US-NIAID (U01 AI 144616). The SARI and ILI surveillance were funded by the NZ Ministry of Health during 2017-2020 and by US-Centers for Disease Control and Prevention (U01IP000480) during 2012-2016. The funding resource has no role in study design; collection, analysis or interpretation of data; writing of reports; nor decision to submit papers for publicationAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was obtained for the SHIVERS (including SARI and ILI surveillance), SHIVERS-II and III cohort studies from the NZ Northern A Health and Disability Ethics Committee (NTX/11/11/102). The ICD-coded influenza hospitalisation data and laboratory-based respiratory virus surveillance data are part of public health surveillance in NZ. It is conducted in accordance with the Public Health Act and thus ethics committee approval was not needed for collection or use of these data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available upon request